RogerSeheultMD

Critical Care Medicine, Pleural Disease, Sleep Medicine

Physician

Dr. Seheult is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Loma Linda University Health Education ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 2000 - 2003
Loma Linda University School of MedicineClass of 2000

PubMed

7 citations
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism.
Jeffrey S. Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune, Yongling Xiao, Jeff Schein, Patrick Lefebvre, Scott Kaatz> ;Research and Practice in Thrombosis and Haemostasis. 2018 Jan 1
6 citations
Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE☆
Alok A. Khorana, Jeffrey S. Berger, Philip S. Wells, Roger Seheult, Veronica Ashton, François Laliberté, Concetta Crivera, Dominique Lejeune, Jeff Schein, Peter Wildgo...> ;Clinical Therapeutics. 2017 Jul 1
13 citations
Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude.
Roger Seheult, Katja Ruh, Gary P. Foster, James D. Anholm> ;Respiratory Physiology & Neurobiology. 2009 Feb 28

Ventilators May Increase Risk of Death from COVID-19February 16th, 2023
Here’s How the End of the COVID-19 Public Health Emergency Could Affect You, According to MDsFebruary 14th, 2023
Commentary: Fuzzy Language Is Setting Back the Fight Against COVID-19July 4th, 2022
Join now to see all